Banks Closed on Memorial Day A Guide to 12 Federal Holidays Impacting Banking Services US Prioritizes AI Integration in Asia Following TrumpXi Summit Workday Shares Climb 5 After Lifting Margin Guidance Citing Artificial Intelligence Momentum Fitness Apps Challenge Personal Trainers Market Disruption or Safety Risk Donald Trump JrBacked Enhanced Games Controversial Steroid Olympics Launches This Weekend with Broader Product Ambitions Chinas APEC Trade Message Commerce Minister Skips Opening Amid Urgent Business Deputy Calls for Regional Cooperation MEC Q1 2026 Earnings NarrowerthanExpected Loss Drives Positive Stock Reaction PAX Q1 2026 Earnings EPS Misses Estimates Shares Decline JXN Q1 2026 Earnings EPS Misses Estimates Stock Declines on Disappointing Quarter Veris Residential Inc VRE Q4 2025 Earnings Surprise EPS Beat Amid Subdued Market Sentiment VLGEA Q1 2025 Earnings Reported EPS of 086 Amid Quiet Investor Response VANI Q1 2026 Earnings Narrower Than Expected Loss Drives Positive Stock Reaction Tailwind 20 Acquisition Corp TDWD Holds Steady at 1000 as SPAC Investors Await Business Combination Catalyst NI Holdings NODK Holds Steady Near Support as Insurance Sector Faces Mixed Signals Estrella Immunopharma Inc ESLA Shows Modest Uptick Amid Sector Stability Zura Bio ZURA Slips 18 as Stock Tests Key Support Levels Proficient Auto Logistics PAL Gains 276 as Buyers Defend Support at 495 World Bank Data Suggests Automation Poses Significant Job Risks in India China and Ethiopia Eagle Point Credit Company Inc ECC Q4 2025 Earnings EPS Surpasses Estimates Stock Gains 21 Woodside Energy WDS Edges Lower as Energy Sector Faces Mixed Signals Amplitech Group Inc Series B Right AMPGZ Q1 2026 Earnings EPS Misses Estimates on Wide Surprise Stock Drops Over 18 BNR Q3 2022 Earnings NarrowerThanExpected Loss as Biotech Company Navigates Challenges RRX Q1 2026 Earnings EPS Beats Estimates as Margins Improve Stock Slides PAYO Q1 2026 Earnings EPS Surpasses Estimates by 3245 Shares Edge Lower ANNX Q1 2026 Earnings EPS Beat Surprise as ClinicalStage Biotech Tightens Cost Control GBTG Q1 2026 Earnings Strong EPS Beat Driven by Operational Efficiency MOLN Q4 2025 Earnings Positive EPS Surprise Highlights Cost Discipline Amid Clinical Progress